ulipristal acetate has been researched along with levonorgestrel in 62 studies
| Studies (ulipristal acetate) | Trials (ulipristal acetate) | Recent Studies (post-2010) (ulipristal acetate) | Studies (levonorgestrel) | Trials (levonorgestrel) | Recent Studies (post-2010) (levonorgestrel) |
|---|---|---|---|---|---|
| 376 | 41 | 347 | 4,818 | 1,004 | 1,763 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 58 (93.55) | 24.3611 |
| 2020's | 4 (6.45) | 2.80 |
| Authors | Studies |
|---|---|
| Gemzell-Danielsson, K | 1 |
| Fine, PM | 1 |
| Jarvis, CI; Melillo, SN; Snow, SE | 1 |
| Duffy, K; Gold, MA | 1 |
| Amir, LH; Chapman, CB; Hobbs, MK; Hussainy, SY; Shelley, JM; Smith, AM; Stewart, K; Taft, AJ | 1 |
| Blithe, D; Cameron, ST; Gainer, E; Glasier, A; Levy, D; Mathe, H; Scherrer, B; Ulmann, A | 1 |
| Bouchard, P | 1 |
| Dalby, J; Hayon, R; Paddock, E; Schrager, S | 1 |
| Martinez, AM; Thomas, MA | 1 |
| Che, Y; Cheng, L; Gülmezoglu, AM | 1 |
| Manyonda, I; Talaulikar, VS | 1 |
| McGough, P; Melvin, L; Webb, A | 1 |
| Bayer, LL; Caughey, AB; Edelman, AB; Rodriguez, MI | 1 |
| Glasier, A | 1 |
| Berger, C; Gemzell-Danielsson, K; P G L, L | 1 |
| Curtis, KM; Godfrey, EM; Rodriguez, MI; Warden, M | 1 |
| Batur, P | 1 |
| Gilbert, L; McKay, RJ | 1 |
| Cheng, L; Gemzell-Danielsson, K; Rabe, T | 1 |
| Baird, AS | 1 |
| Rosen, T | 1 |
| Brache, V; Cochon, L; Croxatto, HB; Deniaud, M | 1 |
| Gemzell-Danielsson, K; Trussell, J | 1 |
| Bastianelli, C; Benagiano, G; Brosens, I; Farris, M | 1 |
| Baird, AS; Trussell, J; Webb, A | 1 |
| Ho, PC; Li, HW; Lo, SS | 1 |
| Berger, C; Gemzell-Danielsson, K; Lalitkumar, PG | 1 |
| Al-Azzawi, F; Berga, S; Birkhaeuser, M; Bouchard, P; Brincat, M; De Melo, NR; Foidart, JM; Gemzell-Danielsson, K; Genazzani, AR; Glasier, A; Kenemans, P; Lunenfeld, B; Maruo, T; Milewicz, A; Naftolin, F; Ng, EH; Schindler, A; Simon, C; Simoncini, T; Simpson, E; Siseles, N; Smetnik, V; Tarlatzis, B; von Schoultz, B | 1 |
| Cleland, K; Raymond, EG; Trussell, J; Westley, E | 1 |
| Bimla Schwarz, E; Corbelli, J | 1 |
| Jamin, C | 1 |
| Agostini, A; Asselin, I; Ben M'barek, I; Bettahar, K; Carbonne, B; David, P; Faucher, P; Fernandez, H; Fournet, P; Goffinet, F; Guilbaud, L; Hassoun, D; Jamin, C; Lachowsky, M; Letombe, B; Levy, G; Trignol-Viguier, N; Vayssiere, C; Vigoureux, S | 1 |
| Batur, P; Cleland, K; McNamara, M; Pickle, S; Wu, J | 1 |
| Schmid, R | 1 |
| Curtis, KM; Jatlaoui, TC; Riley, H | 1 |
| Bullock, H; Salcedo, J | 1 |
| Najera, DB | 1 |
| Bullock, H; Elia, J; Kaneshiro, B; Kurata, N; Salcedo, J; Steele, S; Tschann, M | 1 |
| Abraham, T; Arian, SE; Bartels, CB; Cayton, KC; Chuong, FS; Holthouser, K; Segars, JH | 1 |
| Centini, G; Kashani, BN; Morelli, SS; Petraglia, F; Weiss, G | 1 |
| Kohn, JE; Nucatola, DL | 1 |
| Brand, H; Italia, S | 1 |
| Batur, P; Casey, PM; Kransdorf, LN | 1 |
| Blumenthal, PD; Fok, WK | 1 |
| Bastianelli, C; Benagiano, G; Farris, M; Rosato, E | 1 |
| Kiechle, M; Neuenfeldt, M | 1 |
| Davies, J; Kadir, RA | 1 |
| Lee, JK; Schwarz, EB | 1 |
| Che, Y; Chen, K; Cheng, L; Shen, J; Showell, E | 1 |
| Black, KI; Hussainy, SY | 1 |
| Bellows, BK; Sanders, JN; Schwarz, EB; Tak, CR; Turok, DK | 1 |
| Freye, R | 1 |
| Edelman, AB; Hennebold, JD; Jensen, JT; McCrimmon, S; Messerle-Forbes, M; O'Donnell, A | 1 |
| Agostini, A; Cardinale, C; Hamdaoui, N | 1 |
| Alonso, MJ; Doval, JL; Lete, I; Pérez-Campos, E; Sánchez-Borrego, R; Sellers, G | 1 |
| Bullard, KA; Edelman, AB; Rodriguez, MI; Williams, SM | 1 |
| Cleland, K; Smith, NK; Trussell, J; Wagner, B | 1 |
| Freudewald, L; Ganso, M; Said, A; Schulz, M | 1 |
| Baccaro, LF; Bahamondes, L; Carvalho, N; Castro, S; Fava, M; Peloggia, A | 1 |
| Gawron, LM; Gero, A; Kushner, KL; Sanders, JN; Turok, DK | 1 |
| Aprem, AS; Bagchi, IC; Blithe, DL; Brache, V; Cochon, L; Kannan, A; Kumar, N; Lansiaux, M; Loeven, D; Merkatz, R; Plagianos, M; Sitruk-Ware, R; Sussman, H; Tejada, AS; Vieira, CS; Williams, AR | 1 |
29 review(s) available for ulipristal acetate and levonorgestrel
| Article | Year |
|---|---|
Mechanism of action of emergency contraception.
Topics: Adolescent; Adult; Animals; Contraception, Postcoital; Contraceptives, Postcoital; Female; Genitalia, Female; Humans; Levonorgestrel; Male; Norpregnadienes; Ovarian Follicle; Ovulation; Receptors, Progesterone; Reproduction; Young Adult | 2010 |
Ulipristal acetate for emergency contraception.
Topics: Contraception, Postcoital; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Norpregnadienes; Time Factors | 2011 |
Adolescents and emergency contraception: update 2011.
Topics: Adolescent; Contraception, Postcoital; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Norpregnadienes; Time Factors; United States; United States Food and Drug Administration; Young Adult | 2011 |
Current and future medical treatments for menometrorrhagia during the premenopause.
Topics: Adolescent; Adult; Contraceptives, Oral; Endometrial Neoplasms; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Levonorgestrel; Menorrhagia; Metrorrhagia; Mifepristone; Norpregnadienes; Polyps; Premenopause; Progestins; Randomized Controlled Trials as Topic; Receptors, Progesterone; Uterine Neoplasms | 2011 |
Ulipristal acetate as an emergency contraceptive agent.
Topics: Administration, Oral; Animals; Contraception, Postcoital; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Mifepristone; Norpregnadienes; Receptors, Progesterone; Time Factors | 2012 |
Interventions for emergency contraception.
Topics: Contraception, Postcoital; Contraceptives, Postcoital; Drug Administration Schedule; Female; Humans; Levonorgestrel; Mifepristone; Norpregnadienes; Randomized Controlled Trials as Topic | 2012 |
Progesterone and progesterone receptor modulators in the management of symptomatic uterine fibroids.
Topics: Endometrium; Estrenes; Female; Hormone Antagonists; Humans; Hyperplasia; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Mifepristone; Norpregnadienes; Oximes; Receptors, Progesterone | 2012 |
Emergency contraception: clinical outcomes.
Topics: Contraception Behavior; Contraception, Postcoital; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Norpregnadienes; Pregnancy; Pregnancy Rate; Risk-Taking; Treatment Outcome | 2013 |
Emergency contraception -- mechanisms of action.
Topics: Contraception, Postcoital; Contraceptive Agents, Female; Corpus Luteum; Embryo Implantation; Endometrium; Fallopian Tubes; Female; Fertilization; Humans; Intrauterine Devices, Copper; Levonorgestrel; Male; Norpregnadienes; Ovarian Follicle; Ovulation; Pregnancy; Spermatozoa | 2013 |
Prevention and management of nausea and vomiting with emergency contraception: a systematic review.
Topics: Antiemetics; Contraception, Postcoital; Female; Humans; Levonorgestrel; Nausea; Norpregnadienes; Vomiting | 2013 |
Emergency contraception: separating fact from fiction.
Topics: Abortion, Induced; Contraception, Postcoital; Counseling; Crime Victims; Female; Hospitals; Humans; Intrauterine Devices, Copper; Levonorgestrel; Mifepristone; Nonprescription Drugs; Norpregnadienes; Obesity; Practice Patterns, Physicians'; Pregnancy; Pregnancy, Unplanned; Sex Offenses; United States | 2012 |
Selective progesterone receptor modulators: an update.
Topics: Adenomyosis; Animals; Clinical Trials as Topic; Contraception, Postcoital; Contraceptive Agents, Female; Contraceptives, Postcoital; Endometriosis; Estrenes; Female; Hormone Antagonists; Humans; Leiomyoma; Levonorgestrel; Mifepristone; Norpregnadienes; Oximes; Receptors, Progesterone; Uterine Neoplasms | 2014 |
Emergency contraception.
Topics: Contraception, Postcoital; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Drug Administration Schedule; Female; Health Knowledge, Attitudes, Practice; Humans; Intrauterine Devices, Copper; Levonorgestrel; Mifepristone; Norpregnadienes; Time Factors | 2014 |
Mechanisms of action of oral emergency contraception.
Topics: Contraception, Postcoital; Contraceptive Agents, Female; Contraceptives, Oral; Female; Humans; Levonorgestrel; Norpregnadienes | 2014 |
ISGE statement on oral emergency contraception.
Topics: Contraception, Postcoital; Contraceptive Agents; Female; Humans; Levonorgestrel; Norpregnadienes; Societies, Medical | 2014 |
Emergency contraception review: evidence-based recommendations for clinicians.
Topics: Contraception, Postcoital; Contraceptives, Postcoital; Evidence-Based Medicine; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Norpregnadienes; Practice Guidelines as Topic | 2014 |
Emergency contraception: a review.
Topics: Contraception, Postcoital; Contraceptives, Postcoital; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Male; Nonprescription Drugs; Norpregnadienes; Patient Education as Topic; Pregnancy | 2014 |
[Emergency contraception: efficacy difference between levonorgestrel and ulipristal acetate depending on the follicular size at the time of an unprotected sexual intercourse].
Topics: Coitus; Contraception, Postcoital; Contraceptive Agents, Female; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Norpregnadienes; Organ Size; Ovarian Follicle; Ovulation; Pregnancy; Time Factors; Unsafe Sex | 2015 |
Safety data for levonorgestrel, ulipristal acetate and Yuzpe regimens for emergency contraception.
Topics: Breast Feeding; Contraception, Postcoital; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Female; Humans; Lactation; Levonorgestrel; Norpregnadienes; Pregnancy; Pregnancy Outcome; Treatment Failure | 2016 |
Emergency Contraception: Do Your Patients Have a Plan B?
Topics: Adult; Contraception, Postcoital; Directive Counseling; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Norpregnadienes; Patient Education as Topic; Pregnancy; Time Factors; United States | 2015 |
Emergency contraception: Focus on the facts.
Topics: Contraception; Contraception, Postcoital; Contraceptives, Oral, Hormonal; Cyclooxygenase Inhibitors; Female; Health Services Accessibility; Humans; Intrauterine Devices; Levonorgestrel; Meloxicam; Mifepristone; Norpregnadienes; Ovulation Inhibition; Pregnancy; Thiazines; Thiazoles | 2016 |
An Evidence-based Approach to the Medical Management of Fibroids: A Systematic Review.
Topics: Androgens; Aromatase Inhibitors; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Curcumin; Delayed-Action Preparations; Drugs, Chinese Herbal; Estradiol; Estrenes; Estrogen Receptor Antagonists; Evidence-Based Medicine; Female; Fulvestrant; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Medroxyprogesterone Acetate; Mifepristone; Neoadjuvant Therapy; Norpregnadienes; Oximes; Plant Extracts; Receptors, Progesterone; Selective Estrogen Receptor Modulators; Tea; Uterine Myomectomy; Uterine Neoplasms; Vitamin D; Vitamins | 2016 |
Role of Medical Management for Uterine Leiomyomas.
Topics: Antifibrinolytic Agents; Aromatase Inhibitors; Cabergoline; Cholecalciferol; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Danazol; Dopamine Agonists; Ergolines; Estrenes; Estrogen Antagonists; Female; Gestrinone; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Mifepristone; Norpregnadienes; Oximes; Patient Care Planning; Selective Estrogen Receptor Modulators; Somatostatin; Tranexamic Acid; Uterine Neoplasms; Vitamins | 2016 |
Emergency Contraception.
Topics: Administration, Oral; Attitude of Health Personnel; Body Mass Index; Breast Feeding; Contraception, Postcoital; Contraceptive Agents, Female; Contraceptives, Postcoital; Female; Health Knowledge, Attitudes, Practice; Humans; Intrauterine Devices, Copper; Levonorgestrel; Nonprescription Drugs; Norpregnadienes; Ovulation; Patient Education as Topic; Pregnancy; Prescription Drugs | 2016 |
Update on emergency contraception.
Topics: Adult; Contraception; Contraception, Postcoital; Contraceptive Agents, Female; Contraceptives, Postcoital; Female; Health Services Accessibility; Humans; Intrauterine Devices, Copper; Levonorgestrel; Norpregnadienes; Obesity; Pregnancy | 2016 |
Heavy menstrual bleeding: An update on management.
Topics: Adult; Contraceptive Agents; Disease Management; Female; Hemostasis; Hormones; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Norpregnadienes; Quality of Life; Young Adult | 2017 |
The safety of available and emerging options for emergency contraception.
Topics: Animals; Contraception, Postcoital; Contraceptives, Postcoital; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Norpregnadienes; Pregnancy | 2017 |
Interventions for emergency contraception.
Topics: Contraception, Postcoital; Contraceptives, Postcoital; Drug Administration Schedule; Estradiol; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Mifepristone; Norpregnadienes; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Unsafe Sex | 2017 |
[Emergency contraception: CNGOF Contraception Guidelines].
Topics: Contraception, Postcoital; Female; France; Humans; Intrauterine Devices, Copper; Levonorgestrel; MEDLINE; Norpregnadienes; Pregnancy; Pregnancy Tests; Unsafe Sex | 2018 |
2 trial(s) available for ulipristal acetate and levonorgestrel
| Article | Year |
|---|---|
Ulipristal acetate prevents ovulation more effectively than levonorgestrel: analysis of pooled data from three randomized trials of emergency contraception regimens.
Topics: Adolescent; Adult; Chile; Contraceptives, Postcoital, Hormonal; Contraceptives, Postcoital, Synthetic; Cross-Over Studies; Cyclooxygenase Inhibitors; Dominican Republic; Double-Blind Method; Drug Combinations; Female; Humans; Kaplan-Meier Estimate; Levonorgestrel; Luteinization; Luteinizing Hormone; Meloxicam; Norpregnadienes; Ovarian Follicle; Ovulation; Thiazines; Thiazoles; Young Adult | 2013 |
Pharmacodynamics and pharmacokinetics of a copper intrauterine contraceptive system releasing ulipristal acetate: A randomized proof-of-concept study.
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Norpregnadienes | 2021 |
31 other study(ies) available for ulipristal acetate and levonorgestrel
| Article | Year |
|---|---|
Ulipristal acetate: a new emergency contraceptive that is safe and more effective than levonorgestrel.
Topics: Clinical Trials as Topic; Contraception, Postcoital; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Norpregnadienes; Ovulation Inhibition; Pregnancy; Time Factors; Treatment Outcome | 2011 |
Ella: a new emergency contraceptive.
Topics: Clinical Trials as Topic; Contraceptives, Postcoital; Drug Interactions; Female; Humans; Levonorgestrel; Norpregnadienes | 2011 |
Unintended pregnancy in Australia: what more can we do?
Topics: Abortion, Induced; Adolescent; Adult; Australia; Contraception Behavior; Contraceptives, Postcoital; Female; Forecasting; Health Services Accessibility; Humans; Levonorgestrel; Nonprescription Drugs; Norpregnadienes; Pregnancy; Pregnancy in Adolescence; Pregnancy, Unwanted; Public Opinion; Young Adult | 2011 |
Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel.
Topics: Contraception, Postcoital; Contraceptives, Oral, Combined; Female; Humans; Ireland; Levonorgestrel; Meta-Analysis as Topic; Norpregnadienes; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Risk Assessment; United States; Women's Health Services | 2011 |
Emergency contraception: an underutilized resource.
Topics: Contraception, Postcoital; Contraceptives, Postcoital; Directive Counseling; Estrogens; Female; Health Services Accessibility; Humans; Intrauterine Devices, Copper; Levonorgestrel; Norpregnadienes; Progestins; Triage | 2012 |
Pitfalls of adapting emergency contraception CEU guidance.
Topics: Contraception, Postcoital; Contraceptives, Postcoital; Female; Humans; Intrauterine Devices; Levonorgestrel; Luteinizing Hormone; Norpregnadienes; Risk Factors | 2012 |
The price of emergency contraception in the United States: what is the cost-effectiveness of ulipristal acetate versus single-dose levonorgestrel?
Topics: Contraception, Postcoital; Contraceptive Agents, Female; Cost-Benefit Analysis; Decision Support Techniques; Female; Humans; Levonorgestrel; Monte Carlo Method; Norpregnadienes; Pregnancy; Pregnancy, Unplanned; United States | 2013 |
An emergency contraception algorithm based on risk assessment: changes in clinicians' practice and patients' choices.
Topics: Adolescent; Adult; Algorithms; Contraception, Postcoital; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Norpregnadienes; Patient Preference; Pilot Projects; Practice Patterns, Physicians'; Risk Assessment; Young Adult | 2013 |
Emergency contraception.
Topics: China; Contraception, Postcoital; Contraceptive Agents; Contraceptives, Postcoital; Contraceptives, Postcoital, Synthetic; Ethinyl Estradiol; European Union; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Mifepristone; Norpregnadienes; Ovulation; Pregnancy; Pregnancy, Ectopic; Receptors, Progesterone; Time Factors | 2013 |
Use of ulipristal acetate, levonorgestrel and the copper-intrauterine device for emergency contraception following the introduction of new FSRH guidelines.
Topics: Contraception, Postcoital; Contraceptive Agents; Drug Utilization; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Norpregnadienes; Practice Guidelines as Topic; Practice Patterns, Physicians'; Retrospective Studies; United Kingdom | 2013 |
Emergency contraceptive update.
Topics: Contraception, Postcoital; Contraceptives, Oral, Synthetic; Female; Humans; Levonorgestrel; Norpregnadienes; United States | 2013 |
UPA > LNG, but Not Good Enough.
Topics: Contraceptives, Postcoital, Hormonal; Contraceptives, Postcoital, Synthetic; Female; Humans; Levonorgestrel; Norpregnadienes; Ovarian Follicle; Ovulation | 2013 |
Use of ulipristal acetate and levonorgestrel for emergency contraception: a follow-up study.
Topics: Contraception, Postcoital; Female; Follow-Up Studies; Humans; Intrauterine Devices, Copper; Levonorgestrel; Norpregnadienes; Pregnancy; Retrospective Studies | 2015 |
[Emergency contraceptions: Propositions of the Orthogenics Commission of the French National College of Gynecology and Obstetrics].
Topics: Contraception, Postcoital; Female; France; Gynecology; Humans; Intrauterine Devices, Copper; Levonorgestrel; Norpregnadienes; Obstetrics; Pregnancy; Unsafe Sex | 2015 |
Emergency contraception: A multispecialty survey of clinician knowledge and practices.
Topics: Awareness; Clinical Competence; Contraception, Postcoital; Emergency Medicine; Family Practice; Female; Health Care Surveys; Humans; Intrauterine Devices, Copper; Levonorgestrel; Medicine; Norpregnadienes; Pediatrics; Practice Patterns, Physicians'; Reproductive Health Services | 2016 |
The Cost-Effectiveness of Emergency Hormonal Contraception with Ulipristal Acetate versus Levonorgestrel for Minors in France.
Topics: Adolescent; Contraceptives, Oral, Hormonal; Costs and Cost Analysis; Female; France; Humans; Levonorgestrel; Norpregnadienes; Pregnancy; Pregnancy, Unwanted | 2015 |
Pharmacy access to ulipristal acetate in Hawaii: is a prescription enough?
Topics: Chi-Square Distribution; Contraceptive Agents; Contraceptives, Postcoital; Female; Hawaii; Health Services Accessibility; Humans; Levonorgestrel; Norpregnadienes; Pharmacies; Surveys and Questionnaires | 2016 |
EC4U: results from a pilot project integrating the copper IUC into emergency contraceptive care.
Topics: Choice Behavior; Contraception, Postcoital; Contraceptives, Postcoital; Counseling; Device Removal; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Norpregnadienes; Pilot Projects; United States | 2016 |
Status of Emergency Contraceptives in Europe One Year after the European Medicines Agency's Recommendation to Switch Ulipristal Acetate to Non-Prescription Status.
Topics: Contraceptives, Postcoital; Drug Prescriptions; Europe; European Union; Female; Health Services Accessibility; Humans; Legislation, Drug; Levonorgestrel; Nonprescription Drugs; Norpregnadienes | 2016 |
Emergency contraception: a survey of 1773 women.
Topics: Adolescent; Adult; Age Distribution; Contraception Behavior; Contraception, Postcoital; Contraceptive Agents, Female; Emergency Medical Services; Female; Health Knowledge, Attitudes, Practice; Humans; Levonorgestrel; Marital Status; Menstrual Cycle; Middle Aged; Norpregnadienes; Prospective Studies; Surveys and Questionnaires; Time Factors; Women's Health; Young Adult | 2016 |
Experience with oral emergency contraception since the OTC switch in Germany.
Topics: Adolescent; Adult; Contraception, Postcoital; Contraceptives, Oral; Female; Germany; Humans; Levonorgestrel; Middle Aged; Nonprescription Drugs; Norpregnadienes; Pregnancy | 2017 |
Emergency contraception: Oral and intrauterine options.
Topics: Administration, Oral; Adult; Australia; Contraception, Postcoital; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Norpregnadienes | 2017 |
Cost-effectiveness of emergency contraception options over 1 year.
Topics: Adult; Combined Modality Therapy; Contraception, Postcoital; Contraceptive Agents, Female; Cost-Benefit Analysis; Female; Humans; Intrauterine Devices; Levonorgestrel; Models, Theoretical; Norpregnadienes; Young Adult | 2018 |
[In process].
Topics: Anti-Bacterial Agents; Clinical Trials as Topic; Contraceptives, Postcoital; Drug Interactions; Enterohepatic Circulation; Female; Humans; Levonorgestrel; Norpregnadienes; Pregnancy; Rifampin; Risk Factors | 2016 |
Combined oral contraceptive interference with the ability of ulipristal acetate to delay ovulation: A prospective cohort study.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Healthy Volunteers; Humans; Levonorgestrel; Luteinizing Hormone; Norpregnadienes; Ovarian Follicle; Ovulation; Progesterone; Prospective Studies; Ultrasonography | 2018 |
Prevention of unintended pregnancies by using emergency contraception: the differences between levonorgestrel and ulipristal acetate. A theoretical model using data from a survey on the use of emergency contraception in Spain, 2017.
Topics: Adult; Contraception, Postcoital; Contraceptive Agents, Female; Contraceptive Agents, Hormonal; Cross-Sectional Studies; Female; Humans; Levonorgestrel; Models, Theoretical; Norpregnadienes; Pregnancy; Pregnancy, Unplanned; Spain; Young Adult | 2019 |
Ulipristal acetate compared to levonorgestrel emergency contraception among current oral contraceptive users: a cost-effectiveness analysis.
Topics: Adult; Body Mass Index; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Cost-Benefit Analysis; Female; Humans; Levonorgestrel; Models, Theoretical; Norpregnadienes; Obesity; Pregnancy; Pregnancy, Unplanned; United States; Young Adult | 2019 |
"My BMI is too high for Plan B." A changing population of women seeking ulipristal acetate emergency contraception online.
Topics: Adult; Body Mass Index; Body Weight; Contraception, Postcoital; Contraceptives, Postcoital, Hormonal; Drug Labeling; Female; Humans; Levonorgestrel; Norpregnadienes; Obesity; Pharmaceutical Services, Online; United States | 2020 |
Trends in dispensing oral emergency contraceptives and safety issues: a survey of German community pharmacists.
Topics: Community Pharmacy Services; Contraceptives, Oral; Contraceptives, Postcoital; Female; Germany; Health Care Surveys; Humans; Levonorgestrel; Norpregnadienes; Pharmacists; Professional Role; Referral and Consultation | 2019 |
A randomized controlled pilot study of ulipristal acetate for abnormal bleeding among women using the 52-mg levonorgestrel intrauterine system.
Topics: Adult; Brazil; Contraceptive Agents, Female; Double-Blind Method; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Norpregnadienes; Pilot Projects; Uterine Hemorrhage; Young Adult | 2020 |
Unprotected intercourse in the 2 weeks prior to quick-start initiation of an etonogestrel contraceptive implant with and without use of oral emergency contraception.
Topics: Adolescent; Adult; Contraception, Postcoital; Contraceptive Agents, Hormonal; Contraceptives, Postcoital; Desogestrel; Drug Implants; Female; Humans; Levonorgestrel; Norpregnadienes; Pregnancy; Pregnancy Tests; Risk Assessment; Time Factors; Unsafe Sex; Young Adult | 2020 |